Vascular smooth muscle cell proliferation in restenosis.
Marx, Steven O, Hana Totary-Jain, and Andrew R Marks. 2011. “Vascular Smooth Muscle Cell Proliferation in Restenosis.”. Circulation. Cardiovascular Interventions 4 (1): 104-11.
Search
Search results
20 results found
MicroRNAs and the cellular response to rapamycin: potential role in diagnosis and therapy.
Totary-Jain, Hana, and Andrew R Marks. 2013. “MicroRNAs and the Cellular Response to Rapamycin: Potential Role in Diagnosis and Therapy.”. Cell Cycle (Georgetown, Tex.) 12 (6): 861-2.
Chromosome 19 microRNA cluster enhances cell reprogramming by inhibiting epithelial-to-mesenchymal transition.
Mong, Ezinne F, Ying Yang, Kemal M Akat, John Canfield, Jeffrey VanWye, John Lockhart, John C M Tsibris, et al. 2020. “Chromosome 19 MicroRNA Cluster Enhances Cell Reprogramming by Inhibiting Epithelial-to-Mesenchymal Transition.”. Scientific Reports 10 (1): 3029.
Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity.
Totary-Jain, Hana, Ronit Vogt Sionov, and Ruth Gallily. 2016. “Indomethacin Sensitizes Resistant Transformed Cells to Macrophage Cytotoxicity.”. Immunology Letters 176: 1-7.
Preeclampsia is Associated With Reduced ISG15 Levels Impairing Extravillous Trophoblast Invasion.
Ozmen, Asli, Ozlem Guzeloglu-Kayisli, Selcuk Tabak, Xiaofang Guo, Nihan Semerci, Chinedu Nwabuobi, Kellie Larsen, et al. 2022. “Preeclampsia Is Associated With Reduced ISG15 Levels Impairing Extravillous Trophoblast Invasion.”. Frontiers in Cell and Developmental Biology 10: 898088.
"Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions"
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
Shan, Jian, Thomas B Nguyen, Hana Totary-Jain, Hayes Dansky, Steven O Marx, and Andrew R Marks. 2008. “Leptin-Enhanced Neointimal Hyperplasia Is Reduced by MTOR and PI3K Inhibitors.”. Proceedings of the National Academy of Sciences of the United States of America 105 (48): 19006-11.
Rapamycin resistance is linked to defective regulation of Skp2.
Totary-Jain, Hana, Despina Sanoudou, Cula N Dautriche, Hillary Schneller, Lester Zambrana, and Andrew R Marks. 2012. “Rapamycin Resistance Is Linked to Defective Regulation of Skp2.”. Cancer Research 72 (7): 1836-43.
Tailoring mTOR-based therapy: molecular evidence and clinical challenges.
Santulli, Gaetano, and Hana Totary-Jain. 2013. “Tailoring MTOR-Based Therapy: Molecular Evidence and Clinical Challenges.”. Pharmacogenomics 14 (12): 1517-26.
A selective microRNA-based strategy inhibits restenosis while preserving endothelial function.
Santulli, Gaetano, Anetta Wronska, Kunihiro Uryu, Thomas G Diacovo, Melanie Gao, Steven O Marx, Jan Kitajewski, et al. 2014. “A Selective MicroRNA-Based Strategy Inhibits Restenosis While Preserving Endothelial Function.”. The Journal of Clinical Investigation 124 (9): 4102-14.